×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Korenberg Matthew E

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOSep 23, 2024Option Exercise$52.729,772515,22760,549Sep 24, 2024, 07:41 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOSep 23, 2024Sale$101.229,772989,12158,068Sep 24, 2024, 07:41 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOSep 20, 2024Option Exercise$49.994,982249,05057,052Sep 24, 2024, 07:41 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOSep 20, 2024Sale$104.106,275653,23850,777Sep 24, 2024, 07:41 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOSep 16, 2024Option Exercise$105.003,214337,47052,070Sep 18, 2024, 07:55 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOSep 16, 2024Option Exercise$58.495,774337,69654,008Sep 18, 2024, 07:55 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOAug 23, 2024Sale$104.806,312661,47965,174Aug 26, 2024, 08:15 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOAug 26, 2024Sale$105.6111,3891,202,83154,722Aug 26, 2024, 08:15 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOAug 22, 2024Sale$105.541,157122,11067,211Aug 26, 2024, 08:15 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOAug 09, 2024Sale$98.5018,2451,797,13368,368Aug 13, 2024, 05:21 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & Chief OperatingJun 28, 2024Option Exercise$60.7135021,24786,613Jul 02, 2024, 07:45 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & Chief OperatingMay 13, 2024Sale$84.543,440290,828100,421May 15, 2024, 07:34 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & Chief OperatingMay 14, 2024Sale$85.1014,1581,204,91286,783May 15, 2024, 07:34 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPRESIDENT & CHIEF OPERATINGFeb 15, 2024Option Exercise$74.654,778356,67889,445Feb 16, 2024, 08:10 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPRESIDENT & CHIEF OPERATINGJan 02, 2024Option Exercise$72.312,917210,92894,223Jan 04, 2024, 04:07 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPRESIDENT & CHIEF OPERATINGDec 05, 2023Option Exercise$59.611,984118,26697,140Dec 06, 2023, 03:27 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPRESIDENT & CHIEF OPERATINGJun 30, 2023Option Exercise$56.7837621,34999,124Jul 10, 2023, 06:42 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COOFeb 15, 2023Option Exercise$72.982,890210,91289,679Feb 17, 2023, 07:23 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COODec 28, 2022Option Exercise$66.293,859255,81392,569Dec 30, 2022, 05:00 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EPresident & COONov 30, 2022Option Exercise$72.903,593261,93082,428Dec 01, 2022, 09:42 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJun 30, 2022Option Exercise$75.8416412,43752,532Jul 06, 2022, 08:00 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOFeb 15, 2022Option Exercise$123.683,407421,37846,807Feb 16, 2022, 08:23 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJan 26, 2022Option Exercise$113.683,628412,43150,022Jan 28, 2022, 08:43 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJun 30, 2021Option Exercise$85.9124721,22039,690Jul 02, 2021, 05:13 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOFeb 15, 2021Option Exercise$172.462,309398,21041,318Feb 18, 2021, 06:27 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJan 25, 2021Option Exercise$156.012,111329,33730,933Jan 27, 2021, 07:03 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJun 30, 2020Option Exercise$89.0323821,18925,936Jul 01, 2020, 08:05 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOFeb 15, 2019Option Exercise$120.861,166140,92316,115Apr 24, 2020, 07:24 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFODec 20, 2019Option Exercise$105.872,114223,80920,016Dec 26, 2019, 02:01 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOSep 03, 2019Buy$86.1850043,09117,151Sep 03, 2019, 07:34 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJun 28, 2019Option Exercise$97.0318217,65916,651Jul 02, 2019, 09:49 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJan 23, 2019Option Exercise$111.781,325148,10810,065Jan 25, 2019, 04:30 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOAug 29, 2018Option Exercise$85.7911,540990,01725,099Aug 29, 2018, 08:35 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOAug 29, 2018Sale$256.6918,3574,712,0586,742Aug 29, 2018, 08:35 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOAug 06, 2018Option Exercise$226.74836189,55513,559Aug 07, 2018, 04:35 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOJun 29, 2018Option Exercise$117.8418021,21014,395Jul 03, 2018, 03:27 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOMar 06, 2018Option Exercise$165.8755091,22814,215Mar 06, 2018, 06:36 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EEVP,Finance & Strategy and CFOFeb 15, 2018Option Exercise$157.18680106,88210,013Feb 16, 2018, 05:37 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFODec 28, 2017Option Exercise$138.661,530212,15010,367Dec 29, 2017, 09:17 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFONov 17, 2017Sale$142.636,559935,5108,147Nov 17, 2017, 05:11 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFOAug 06, 2017Option Exercise$122.0660974,33514,706Aug 08, 2017, 05:50 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFOJun 30, 2017Option Exercise$87.1324321,17115,315Jul 05, 2017, 06:44 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFOAug 06, 2016Option Exercise$123.3060975,0909,457Feb 28, 2017, 06:27 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFOFeb 15, 2017Option Exercise$104.2839140,7739,106Feb 28, 2017, 06:27 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFOFeb 24, 2017Option Exercise$100.381,051105,49911,505Feb 28, 2017, 06:27 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFODec 30, 2016Option Exercise$86.37403,45510,106Jan 03, 2017, 04:38 PM
LGNDLIGAND PHARMACEUTICALS INCKorenberg Matthew EVP, Finance and CFOJun 30, 2016Option Exercise$87.1019617,07210,066Jul 05, 2016, 07:58 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe